CARBIOTIX AB (CRBX.ST)
SEK 8.58
(-2.72%)
SEK 8.58
(-2.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.77 Million | -10.62 Million | -11.99 Million | -5.15 Million | -5.18 Million | -1.89 Million |
| Net Income | -13.47 Million | -12.25 Million | -10.46 Million | -5.97 Million | -5.39 Million | -1.99 Million |
| Depreciation & Amortization | 187.09 Thousand | 108.33 Thousand | 51.33 Thousand | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.51 Million | 1.51 Million | -1.57 Million | 826.92 Thousand | 223.14 Thousand | 126.52 Thousand |
| Other non-cash items | 936.72 Thousand | -972.00 | -8295.00 | -5971.00 | -12.12 Thousand | -24.02 Thousand |
| Investing Cash Flow | -3.04 Million | -3.29 Million | -3.21 Million | -3.95 Million | -3.31 Million | -1.6 Million |
| Investments in PPE | -3.04 Million | -3.29 Million | -3.21 Million | -3.95 Million | -3.31 Million | -1.6 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.82 Million | - | - | - | - | - |
| Financing Cash Flow | 9.26 Million | 13.81 Million | 14.89 Million | 9.85 Million | 13.91 Million | 4.5 Million |
| Debt repayment | -3 Million | - | - | -100 Thousand | -100 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 9.26 Million | 13.81 Million | 14.89 Million | 9.95 Million | 14.01 Million | 4.5 Million |
| Other Financing Activities | - | - | - | -100 Thousand | -100 Thousand | - |
| Accounts receivables | -389.76 Thousand | - | -2.27 Million | -262.61 Thousand | 112.97 Thousand | - |
| Accounts payables | -172.76 Thousand | 453.07 Thousand | 526.73 Thousand | -122.22 Thousand | 116.74 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.07 Million | 1.06 Million | 174.06 Thousand | 1.21 Million | -6577.00 | - |
| Cash at beginning of period | 7.21 Million | 7.32 Million | 7.63 Million | 6.89 Million | 1.47 Million | 473.05 Thousand |
| Cash at end of period | 2.65 Million | 7.21 Million | 7.32 Million | 7.63 Million | 6.89 Million | 1.47 Million |
| Capital Expenditure | -3.04 Million | -3.29 Million | -3.21 Million | -3.95 Million | -3.31 Million | -1.6 Million |
| Effect of forex changes on cash | -1.00 | - | - | - | - | 1.00 |
| Net cash flow / Change in cash | -4.55 Million | -110.07 Thousand | -316.57 Thousand | 744.74 Thousand | 5.41 Million | 1 Million |
| Free Cash Flow | -13.82 Million | -13.92 Million | -15.21 Million | -9.11 Million | -8.49 Million | -3.49 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.5 Million | -3.99 Million | -4.25 Million | -13.47 Million | -2.4 Million | -3.72 Million |
| Depreciation & Amortization | 36.57 Thousand | 43.31 Thousand | 54.99 Thousand | 187.09 Thousand | 45.33 Thousand | 46.94 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 11.31 Thousand | -3.15 Million | 4.25 Million | 2.51 Million | -1.19 Million | 2.19 Million |
| Other non-cash items | -271.09 Thousand | 105.63 Thousand | -877 Thousand | 936.72 Thousand | 65.00 | -174.49 Thousand |
| Investing Cash Flow | -469.22 Thousand | -473.26 Thousand | -664.7 Thousand | -3.04 Million | -801.42 Thousand | -883.49 Thousand |
| Investments in PPE | -469.22 Thousand | -473.26 Thousand | -664.7 Thousand | -3.04 Million | -801.42 Thousand | -883.49 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -469.22 Thousand | - | - | - | - | - |
| Financing Cash Flow | 93.9 Thousand | 12.2 Million | -9999.00 | 9.26 Million | -3426.00 | 9.28 Million |
| Debt repayment | - | - | -3 Million | -3 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -3426.00 | - |
| Common Stock Issuance | 93.9 Thousand | 12.2 Million | -9999.00 | 9.26 Million | -3426.00 | 9.28 Million |
| Other Financing Activities | - | - | - | - | 3426.00 | - |
| Accounts receivables | 587.48 Thousand | -386.16 Thousand | 628.34 Thousand | -389.76 Thousand | -955.35 Thousand | 1.79 Million |
| Accounts payables | -243.25 Thousand | 367.16 Thousand | 358.64 Thousand | -172.76 Thousand | -108.65 Thousand | 302.88 Thousand |
| Inventory | - | - | - | - | 1.00 | -1.00 |
| Other working capital | -332.92 Thousand | -3.14 Million | 3.26 Million | 3.07 Million | -126.19 Thousand | 93.02 Thousand |
| Cash at beginning of period | 7.28 Million | 2.65 Million | 3.28 Million | 7.21 Million | 7.63 Million | 893.27 Thousand |
| Cash at end of period | 2.45 Million | 7.28 Million | 2.65 Million | 2.65 Million | 3.28 Million | 7.63 Million |
| Capital Expenditure | -469.22 Thousand | -473.26 Thousand | -664.7 Thousand | -3.04 Million | -801.42 Thousand | -883.49 Thousand |
| Effect of forex changes on cash | - | - | -1.00 | -1.00 | 1.00 | - |
| Net cash flow / Change in cash | -4.82 Million | 4.62 Million | -622.34 Thousand | -4.55 Million | -4.35 Million | 6.74 Million |
| Free Cash Flow | -4.92 Million | -7.58 Million | -612.34 Thousand | -13.82 Million | -4.34 Million | -2.53 Million |
HOVR
002597
603697
004830
PSGR
9924